PECO Air Purification in Hospital Rooms to Improve Health Outcomes for Pediatric Respiratory Distress
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03647397|
Recruitment Status : Completed
First Posted : August 27, 2018
Last Update Posted : May 17, 2019
|Condition or disease||Intervention/treatment||Phase|
|Asthma Pneumonia Respiratory Distress Syndrome||Device: Photo Electrochemical Oxidation (PECO) for Air Purification||Not Applicable|
The goal of this study is to assess whether using PECO to purify air in a hospital can improve health outcomes for pediatric patients with respiratory distress.
The results of this study will be used in three primary ways:
- As evidence to support an installation of PECO in hospital HVAC systems to improve the standard of care for patients with respiratory distress
- Towards dissemination efforts through publication in a peer-reviewed journal and presentation at national and international conferences
- For informing healthcare providers and stakeholders
There are no plans to repeat this study with other hospital partners
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||274 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||Use of PECO Air Purification in Hospital Rooms to Improve Health Outcomes for Pediatric Respiratory Distress|
|Actual Study Start Date :||August 8, 2018|
|Actual Primary Completion Date :||December 31, 2018|
|Actual Study Completion Date :||December 31, 2018|
All pediatric patients admitted for respiratory distress will have the intervention of Photo Electrochemical Oxidation (PECO) for Air Purification.
Device: Photo Electrochemical Oxidation (PECO) for Air Purification
PECO air purifiers from Molekule will be placed in every patient room. Health metrics will be tracked for patients whose diagnosis is respiratory distress.
- Length of stay [ Time Frame: 5 months ]Total length of hospital stay for patient
- Readmission rate [ Time Frame: 1 months ]Rate of readmission within 30 days of discharge
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03647397
|United States, Illinois|
|Mercyhealth Hospital - Rockton Avenue|
|Rockford, Illinois, United States, 61103|
|Principal Investigator:||Nikhil Rao||Molekule|